Recrudescence of livedoid vasculopathy induced by COVID-19.
作者信息
Valentim Flávia de Oliveira, Tsutsui Giuliane Minami, Miot Hélio Amante
机构信息
Departamento de Dermatologia e Radioterapia, FMB-UNESP, Botucatu, Brazil.
出版信息
Int J Dermatol. 2021 May;60(5):e185-e187. doi: 10.1111/ijd.15423. Epub 2021 Feb 2.
Abstract
摘要
相似文献
1
Recrudescence of livedoid vasculopathy induced by COVID-19.由新型冠状病毒肺炎（COVID-19）诱发的类癌样血管病复发
Int J Dermatol. 2021 May;60(5):e185-e187. doi: 10.1111/ijd.15423. Epub 2021 Feb 2.
2
Secondary livedoid vasculopathy following SARS-CoV-2 infection.新型冠状病毒感染后的继发性类脂质渐进性坏死性血管病
J Eur Acad Dermatol Venereol. 2024 May;38(5):e368-e370. doi: 10.1111/jdv.19729. Epub 2023 Dec 14.
3
Thrombotic occlusive vasculopathy in a skin biopsy from a livedoid lesion of a patient with COVID-19.一名新冠肺炎患者类脂质渐进性坏死病变皮肤活检中的血栓闭塞性血管病。
Br J Dermatol. 2020 Sep;183(3):591-593. doi: 10.1111/bjd.19222. Epub 2020 Jun 28.
4
Relapsing symmetric livedo reticularis in a patient with COVID-19 infection.一名新冠肺炎感染患者出现复发性对称性网状青斑。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e684-e686. doi: 10.1111/jdv.16773. Epub 2020 Aug 4.
5
Livedo Reticularis Associated with COVID-19.与新型冠状病毒肺炎相关的网状青斑
Intern Med. 2022 Feb 1;61(3):441. doi: 10.2169/internalmedicine.8033-21. Epub 2021 Nov 13.
6
Exacerbation of livedoid vasculopathy after coronavirus disease 2019.2019冠状病毒病后类脂质渐进性坏死性血管病加重
Eur J Dermatol. 2022 Jan 1;32(1):129-131. doi: 10.1684/ejd.2022.4200.
7
New hope for patients with livedoid vasculopathy.类脂质渐进性坏死性血管病患者的新希望。
Lancet Haematol. 2016 Feb;3(2):e56-7. doi: 10.1016/S2352-3026(15)00288-4. Epub 2016 Jan 16.
8
Livedoid vasculopathy: how to diagnose and how to treat?萎缩性硬化性苔藓样血管病：如何诊断及如何治疗？
J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1627-1628. doi: 10.1111/jdv.15830.
9
Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?狼疮患者的皮肤白细胞碎裂性血管病和复发性血栓形成：抗磷脂抗体阴性的抗磷脂综合征？
Lupus. 2010 Oct;19(11):1340-3. doi: 10.1177/0961203310373783. Epub 2010 Jul 21.
10
Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series.静脉注射免疫球蛋白治疗难治性类脂质渐进性坏死性血管病：病例系列分析
Dermatol Ther. 2020 Mar;33(2):e13229. doi: 10.1111/dth.13229. Epub 2020 Feb 4.
引用本文的文献
1
Pentoxifylline in COVID-19 and considerations for its research in long COVID.己酮可可碱在新冠病毒病中的应用及其在新冠后综合征研究中的考量
Inflamm Res. 2024 Dec;73(12):2057-2068. doi: 10.1007/s00011-024-01942-0. Epub 2024 Oct 24.
2
A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy.关于萎缩性硬化性苔藓样血管病的发病机制、关联因素、临床发现及治疗的全面综述。
Front Med (Lausanne). 2022 Dec 8;9:993515. doi: 10.3389/fmed.2022.993515. eCollection 2022.
3
Livedoid vasculopathy: A review with focus on terminology and pathogenesis.皮肤白细胞碎裂性血管病：术语和发病机制综述。
Vasc Med. 2022 Dec;27(6):593-603. doi: 10.1177/1358863X221130380. Epub 2022 Oct 26.
4
Livedoid vasculopathy - A diagnostic and therapeutic challenge.萎缩性硬化性苔藓样血管病——诊断与治疗的挑战。
Front Med (Lausanne). 2022 Oct 3;9:1012178. doi: 10.3389/fmed.2022.1012178. eCollection 2022.
5
The clot thickens with COVID-19 and cryofibrinogenemia: A thought-provoking association.新冠病毒感染与冷纤维蛋白原血症时血凝块增厚：一个引人深思的关联。
JAAD Case Rep. 2022 Jun;24:24-28. doi: 10.1016/j.jdcr.2022.03.025. Epub 2022 Apr 4.
6
Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.萎缩性硬化性苔藓样血管病：一种诊断与管理的多学科临床方法。
Int J Womens Dermatol. 2021 Sep 2;7(5Part A):588-599. doi: 10.1016/j.ijwd.2021.08.013. eCollection 2021 Dec.
本文引用的文献
1
From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy.从皮肤病到 COVID-19：抗凝、抑制炎症和高压氧治疗的理由。
Dermatol Ther. 2021 Jan;34(1):e14565. doi: 10.1111/dth.14565. Epub 2020 Nov 30.
2
Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients.COVID-19 患者的血管闭塞是由于内皮细胞和血管平滑肌细胞的生长所致。
Int J Dermatol. 2021 Jan;60(1):73-80. doi: 10.1111/ijd.15300. Epub 2020 Nov 12.
3
COVID-19 cutaneous manifestations: simplifying the confusion.
Int J Dermatol. 2021 Jan;60(1):3-4. doi: 10.1111/ijd.15281. Epub 2020 Nov 6.
4
Self-reported cutaneous manifestations in 1429 Brazilian COVID-19-infected patients.1429例巴西新冠病毒感染患者的自我报告皮肤表现
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e172-e173. doi: 10.1111/jdv.17024. Epub 2020 Nov 24.
5
COVID-19: An overview for dermatologists.新型冠状病毒肺炎：皮肤科医生的概述。
Int J Dermatol. 2020 Dec;59(12):1437-1449. doi: 10.1111/ijd.15257. Epub 2020 Oct 27.
6
Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events?解开新冠病毒感染的血栓形成状态之谜：既往存在的易栓风险特征是否是导致血栓形成事件异质性的原因？
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620952884. doi: 10.1177/1076029620952884.
7
Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19.严重 COVID-19 相关凝血病伴发 livedoid 和紫癜性皮肤疹。
JAMA Dermatol. 2020 Sep 1;156(9):1-3. doi: 10.1001/jamadermatol.2020.2800.
8
Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.新型冠状病毒感染的皮肤表现：临床最新进展。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2499-2504. doi: 10.1111/jdv.16774. Epub 2020 Jul 20.
9
Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems.揭开新冠病毒细胞因子风暴之谜：从皮肤到器官系统。
Dermatol Ther. 2020 Nov;33(6):e13859. doi: 10.1111/dth.13859. Epub 2020 Jul 7.
10
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.COVID-19 皮肤表现分类：西班牙 375 例快速前瞻性全国共识研究。
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
Zotero 插件